Pilgrim's Pride (PPC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
A special meeting is scheduled for December 4, 2024, to vote on amending the Certificate of Incorporation, with no other matters on the agenda.
The amendment aims to adjust board composition to align with JBS's ownership and enable tax consolidation with JBS USA, potentially yielding significant tax and administrative benefits.
The board unanimously recommends voting in favor of the amendment, which would become effective upon filing with the Delaware Secretary of State.
Forward-looking statements highlight potential risks, including industry volatility, regulatory changes, and operational disruptions.
Voting matters and shareholder proposals
The sole proposal is to approve an amendment to the Certificate of Incorporation, with options to vote for, against, or abstain.
Abstentions and broker non-votes will have the same effect as votes against the proposal.
Stockholder proposals for the 2025 annual meeting must be submitted by January 1, 2025, or December 2, 2024, for inclusion in proxy materials.
Board of directors and corporate governance
The amendment would increase the board to 10 directors when JBS holds 80%–90% of shares: 8 JBS Directors and 2 Equity Directors.
At least two JBS Directors must be independent and financially literate, qualified for audit committee service.
Special Nominating Committees (JBS and Equity) have exclusive authority to nominate their respective directors.
Latest events from Pilgrim's Pride
- 2025 net revenues hit $18.5B, adjusted EBITDA $2.3B, with strong U.S./Europe and $2B returned.PPC
Q4 202512 Feb 2026 - Q2 2024 net income and margins surged on strong sales, cost controls, and global demand.PPC
Q2 20242 Feb 2026 - Q3 net sales up 5.2% to $4.6B, adjusted EBITDA margin doubled to 14.4% on strong U.S. and EU results.PPC
Q3 202417 Jan 2026 - Record profitability and margin expansion achieved through operational excellence and branded growth.PPC
Q4 20248 Jan 2026 - Q1 2025 net sales rose 2.3% to $4.5B, with adjusted EBITDA margin at 12% and a $1.5B dividend paid.PPC
Q1 202525 Dec 2025 - 2024 results highlight growth, sustainability, and key governance votes at the annual meeting.PPC
Proxy Filing1 Dec 2025 - Vote sought on board structure change to enable tax consolidation with JBS USA; Board recommends approval.PPC
Proxy Filing1 Dec 2025 - Vote sought on amending the charter to enable tax consolidation and adjust board composition.PPC
Proxy Filing1 Dec 2025 - Q2 2025 saw 4.3% sales growth, strong margins, and a $500M special dividend amid robust demand.PPC
Q2 20255 Nov 2025